Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2007-10-02
2007-10-02
Parkin, Jeffrey S. (Department: 1648)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C435S069100, C530S350000
Reexamination Certificate
active
10505666
ABSTRACT:
The present invention relates to a purified or isolated obligate domain-swapped dimer of CVN and a composition comprising the same.
REFERENCES:
patent: 5821081 (1998-10-01), Boyd et al.
patent: 5843882 (1998-12-01), Boyd et al.
patent: 5962653 (1999-10-01), Boyd et al.
patent: 6015876 (2000-01-01), Boyd
patent: 6193982 (2001-02-01), Boyd
patent: WO 00/53213 (2000-09-01), None
Mori T. Analysis of Sequence Requirements for Biological Activity of Cyanovirin-N, a Potent HIV-Inactivating Protein. Biochemical and Biophysical Research Communications 1997, vol. 238, p. 218-222.
Han et al. Discovery of a Stable Dimeric Mutant of Cyanovirin-N (CV-N) from a T7 Phage-Displayed CV-N Mutant Library 2002, Biochemical and Biophysical Research Communications vol. 292, p. 1036-1043.
Bergdoll et al.,Structure, 5, 391-401 (1997).
Bewley,J. Am. Chem. Soc., 123, 1014-1015 (2001).
Bewley et al.,J. Am. Chem. Soc., 123, 3892-3902 (2001).
Bewley et al.,J. Am. Chem. Soc., 122, 6009-6016 (2000).
Bewley et al.,Nat. Struct. Biol., 5(7), 571-578 (1998).
Bewley,Structure, 9, 931-940 (2001).
Boyd et al.,Antimicrob Agents Chemother., 41(7), 1521-1530 (1997).
Clore et al.,Biochem., 29, 7387-7401 (1990).
Dey et al.,J. Virol., 74(10), 4562-4569 (2000).
Morgan et al.,AIDS Res. Hum. Retroviruses, 10(11), 1507-1515 (1994).
Tjandra et al.,J. Biomol. NMR, 8, 273-284 (1996).
Yang et al.,J. Mol. Biol., 288, 403-412 (1999).
Barrientos et al.,PROTEINS: Structure, Function, and Genetics, 46, 153-160 (2002).
Barrientos et al.,Structure, 10, 673-686 (2002).
Kelley et al.,J. Am. Chem. Soc., 124, 3210-3211 (2002).
Humphrey Louise
Leydig , Voit & Mayer, Ltd.
Parkin Jeffrey S.
United States of America, repesented by the Secretary, Departmen
LandOfFree
Obligate domain-swapped dimer of cyanovirin with enhanced... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Obligate domain-swapped dimer of cyanovirin with enhanced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Obligate domain-swapped dimer of cyanovirin with enhanced... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3896922